PACS Group (NYSE:PACS) Raised to Strong-Buy at Zacks Research

Posted by George Bondi on Aug 12th, 2026

PACS Group (NYSE:PACS – Get Free Report) was upgraded by equities researchers at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports.

A number of other equities research analysts also recently commented on the company. UBS Group boosted their target price on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Weiss Ratings cut PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Royal Bank Of Canada lifted their price objective on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research note on Thursday, August 6th. Oppenheimer upped their price objective on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday. Finally, Truist Financial increased their target price on PACS Group from $52.00 to $62.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $56.00.

Check Out Our Latest Report on PACS

PACS Group Stock Performance

Shares of NYSE PACS opened at $45.11 on Monday. The company has a market cap of $7.14 billion, a P/E ratio of 26.23, a P/E/G ratio of 1.45 and a beta of -0.08. PACS Group has a 52-week low of $7.50 and a 52-week high of $49.49. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The firm’s fifty day moving average is $42.16 and its two-hundred day moving average is $37.99.

PACS Group (NYSE:PACS – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, analysts anticipate that PACS Group will post 2.23 EPS for the current fiscal year.

Insider Transactions at PACS Group

In other news, Director Mark Hancock sold 4,966 shares of the company’s stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $45.06, for a total transaction of $223,767.96. Following the sale, the director directly owned 53,920,512 shares in the company, valued at approximately $2,429,658,270.72. This represents a 0.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle Renee Lewis sold 4,137 shares of the company’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $45.04, for a total transaction of $186,330.48. Following the sale, the chief accounting officer owned 355,338 shares in the company, valued at $16,004,423.52. This represents a 1.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 796,524 shares of company stock worth $31,611,396. Insiders own 70.10% of the company’s stock.

Institutional Investors Weigh In On PACS Group

Several institutional investors have recently modified their holdings of the stock. Alyeska Investment Group L.P. boosted its holdings in shares of PACS Group by 159.5% in the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after purchasing an additional 1,382,984 shares during the period. Marshall Wace LLP raised its holdings in PACS Group by 348.6% during the 3rd quarter. Marshall Wace LLP now owns 1,010,906 shares of the company’s stock valued at $13,880,000 after buying an additional 785,537 shares during the period. Ameriprise Financial Inc. raised its holdings in PACS Group by 120.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,129,612 shares of the company’s stock valued at $14,595,000 after buying an additional 617,124 shares during the period. Dimensional Fund Advisors LP lifted its position in PACS Group by 370.2% in the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after buying an additional 614,250 shares during the last quarter. Finally, 8 Knots Management LLC bought a new stake in PACS Group in the fourth quarter worth $23,421,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.